HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doreen Schmidl Selected Research

moxaverine

3/2012The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Doreen Schmidl Research Topics

Disease

11Dry Eye Syndromes (Dry Eye Syndrome)
01/2021 - 04/2015
7Glaucoma
02/2022 - 08/2011
5Hyperoxia
09/2022 - 04/2014
5Eye Diseases (Eye Disease)
01/2020 - 03/2012
4Macular Degeneration (Age-Related Maculopathy)
01/2022 - 03/2012
4Diabetic Retinopathy (Retinopathy, Diabetic)
06/2020 - 10/2015
3Hypoxia (Hypoxemia)
09/2022 - 11/2014
3Hyperemia
01/2020 - 01/2018
2Ganglion Cysts (Ganglion)
02/2022 - 01/2021
2Open-Angle Glaucoma (Glaucoma, Open Angle)
02/2022 - 03/2012
2Vascular Diseases (Vascular Disease)
07/2021 - 02/2015
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 01/2013
1Type 2 Diabetes Mellitus (MODY)
03/2022
1Pregnancy Complications
09/2021
1Multiple Sclerosis
01/2021
1Optic Neuritis (Retrobulbar Neuritis)
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020
1Microaneurysm
06/2020
1Diabetes Mellitus
06/2020
1Macular Edema
01/2020
1Inflammation (Inflammations)
01/2020
1Ocular Hypertension (Glaucoma, Suspect)
07/2018
1Corneal Injuries
10/2016
1Keratoconus
10/2016
1Retinal Diseases
10/2015
1Chronic Obstructive Pulmonary Disease (COPD)
02/2013

Drug/Important Bio-Agent (IBA)

17Retinaldehyde (Retinal)IBA
09/2022 - 11/2011
9Oxygen (Dioxygen)IBA
09/2022 - 02/2013
5Ophthalmic Solutions (Eye Drops)IBA
01/2020 - 04/2015
2Tyrosine (L-Tyrosine)FDA Link
03/2022 - 11/2014
2Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2020
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2020 - 01/2020
2LubricantsIBA
11/2018 - 06/2017
2Hyaluronic Acid (Hyaluronan)IBA
11/2018 - 01/2018
2ZincIBA
12/2014 - 04/2014
2Complement Factor H (Factor H)IBA
11/2014 - 01/2013
1NitrogenIBA
09/2022
1Carnitine (L-Carnitine)FDA LinkGeneric
03/2022
1Valine (L-Valine)FDA Link
03/2022
1Uric Acid (Urate)IBA
03/2022
1afliberceptIBA
01/2022
1Pharmaceutical PreparationsIBA
07/2021
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Estradiol (Delestrogen)FDA LinkGeneric
01/2021
1HomocysteineIBA
01/2020
1perfluorohexyl-octanIBA
01/2020
1Nerve Growth Factor (NGF)IBA
01/2020
1tafluprostIBA
07/2018
1ProstaglandinsIBA
07/2018
1TrehaloseIBA
01/2018
1GelsIBA
06/2017
1ChitosanIBA
01/2017
1Acetylcysteine (Siran)FDA LinkGeneric
01/2017
1CollagenIBA
10/2016
1Lubricant Eye Drops (Artificial Tears)IBA
04/2015
1Hormones (Hormone)IBA
02/2015
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2014
1Carotenoids (Carotene)IBA
12/2014
1Histidine (L-Histidine)FDA Link
11/2014
1AntioxidantsIBA
04/2014
1Complement System Proteins (Complement)IBA
01/2013
1moxaverineIBA
03/2012
14-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA
08/2011

Therapy/Procedure

4Therapeutics
07/2018 - 02/2015
3Lasers (Laser)
02/2022 - 01/2018
1Corneal Cross-Linking
10/2016
1Aftercare (After-Treatment)
04/2015
1Drug Therapy (Chemotherapy)
03/2015